Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. (Q36854654)

16 August 2017

1 reference

title

Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. (English)

1 reference

16 August 2017

1 reference

S Mitchell Harman

1

1 reference

16 August 2017

language of work or name

1 reference

1 December 2006

1 reference

16 August 2017

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

254-269

1 reference

Postmenopausal hormone replacement therapy as antiatherosclerotic therapy

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

A prospective study of postmenopausal estrogen therapy and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Stroke incidence and risk factors for stroke in Copenhagen, Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Estrogen replacement therapy and protection from acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Systolic blood pressure and cardiovascular mortality among 13,740 Dutch women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Inflammatory markers and the risk of coronary heart disease in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Molecular and cellular basis of cardiovascular gender differences

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Regression of Atherosclerosis in Female Monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Estrogen plus progestin and the risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980214-7

7 January 2021

10.1016/S1550-8579(06)80214-7

Identifiers

DOI

1 reference

release_cgbgyv7zqjgmzm2wigoblsmjky

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cgbgyv7zqjgmzm2wigoblsmjky

24 November 2022

mapped directly with Wikidata item

1 reference